The monoclonal antibody ca37, developed against candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo

HIGHLIGHTS

• who: The monoclonal antibody Ca and colleagues from the Faculty University of have published the research work: The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo, in the Journal: Scientific Reports Scientific Reports of 26/01/2020
• how: Data showed that exposure to Ca37 had no significant effect on fungal growth (Fig 3ab). The role of C. albicans Adh1 in virulence and the ability of the Ca37 antibody to inhibit this pathogen were tested in_vivo using Galleria mellonella as an invertebrate infection model (Fig 5). Data . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.